Abstract
Albumin-conjugated multilayered nanoemulsion (albumin-MNE) of methyl prednisolone (MP) was developed to ensure the specificity of the drug at the spinal cord injury (SCI) site. MNE was prepared by emulsification followed by ionic deposition of oppositely charged polymer followed by albumin conjugation using N-hydroxysuccinimide. Prepared nanoemulsion was characterized for particle size, polydispersity index (PDI), zeta potential (Zp), pH, viscosity, and entrapment efficiency. It was further evaluated for shape and morphological analysis, in vitro release, cell viability, and in vivo efficacy against post SCI-like conditions in terms of behavioral assessment, histopathological evaluation, and immunoflorescence assay of the histological sections showing Bax-driven apoptosis. Entrapment efficiency, particle size, PDI, and Zp of spherical-shaped, smooth-surfaced MNE droplets were found to be 68.9%, 83.2 ± 14.4 nm, 0.231, and + 62.7 mV, respectively. In vitro release of MP from MNE and albumin-MNE was observed to be 68.5 and 72.2% after 96th hour of the study. MNE showed higher viability of astrocytes than MP solution. Albumin-MNE improved behavior of SCI rat and histopathological conditions in a very effective manner when compared with MNE. Immunoflorescence assay reveals explicit decline in mitochondrial-mediated apoptosis by sub-cellular upregulation of Bax at spinal cord injury site. In conclusion, albumin-MNE delivered MP specifically at SCI site and avoided its instant availability inside astrocytes culture. On account of which the chitosan stabilized, lecithin-emulsified, multilayered nanoemulsion of MP depicts higher efficacy and safety than MNE and may offer safe and effective mean for the treatment of post SCI-like conditions in human.
Similar content being viewed by others
Reference
Bin S, Zhou N, Pan J, Pan F, Wu X-F, Zhou Z-H. Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats. Drug Dev Ind Pharm. 2017;43(6):1033–41.
Rosado IR, Lavor MS, Alves EG, Fukushima FB, Oliveira KM, Silva CM, et al. Effects of methylprednisolone, dantrolene, and their combination on experimental spinal cord injury. Int J Clin Exp Pathol. 2014;7(8):4617–26.
Kotipatruni RR, Dasari VR, Veeravalli KK, Dinh DH, Fassett D, Rao JS. p53- and Bax-mediated apoptosis in injured rat spinal cord. Neurochem Res. 2011;36(11):2063–74.
Kim YT, Caldwell JM, Bellamkonda RV. Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury. Biomaterials. 2009;30(13):2582–90.
Sloka JS, Stefanelli M. The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler. 2005;11(4):425–32.
Anderson BD, Conradi RA, Knuth KE, Nail SL. Strategies in the design of solution-stable, water-soluble prodrugs II: properties of micellar prodrugs of methylprednisolone. J Pharm Sci. 1985;74(4):375–81.
Haughey DB, Jusko WJ. Bioavailability and nonlinear disposition of methylprednisolone and methylprednisone in the rat. J Pharm Sci. 1992;81(2):117–21.
Chen C-L, Chang S-F, Lee D, Yang L-Y, Lee Y-H, Hsu CY, et al. Bioavailability effect of methylprednisolone by polymeric micelles. Pharm Res. 2008;25(1):39–47.
Weiner GM, Faraji AH, Ducruet AF. The use of nanotechnology to improve the neuroprotective effects of adenosine in stroke and spinal cord injury. Neurosurgery. 2015;76(4):N21–2.
Chen B, He J, Yang H, Zhang Q, Zhang L, Zhang X, et al. Repair of spinal cord injury by implantation of bFGF-incorporated HEMA-MOETACL hydrogel in rats. Sci Rep. 2015;5:9017.
Shen B, Ningfeng Z, Jie P, Fumin P, Xiao-Feng W, Zi-Hui Z. Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats. Drug Dev Ind Pharm. 2017;43(6):1033–41.
McClements DJ. Non-covalent interactions between proteins and polysaccharides. Biotechnol Adv. 2006;24(6):621–5.
McClements DJ. Encapsulation, protection, and release of hydrophilic active components: potential and limitations of colloidal delivery systems. Adv Colloid Interf Sci. 2015;219:27–53.
Guzey D, McClements DJ. Formation, stability and properties of multilayer emulsions for application in the food industry. Colloid Interface Sci. 2006;128–130:227–48.
Klinkesorn U, Sophanodora P, Chinachoti P, Decker EA, McClements DJ. Characterization of spray-dried tuna oil emulsified in two-layered interfacial membranes prepared using electrostatic layer-by-layer deposition. Food Res Int. 2006;39(4):449–57.
Rai VK, Dwivedi H, Yadav NP, Chanotiya CS, Saraf SA. Solubility enhancement of miconazole nitrate: binary and ternary mixture approach. Drug Dev Ind Pharm. 2014;40(8):1021–9.
Shaw LA, McClements DJ, Decker EA. Spray-dried multilayered emulsions as a delivery method for omega-3 fatty acids into food systems. J Agric Food Chem. 2007;55(8):3112–9.
Mishra N, Yadav KS, Rai VK, Yadav NP. Polysaccharide encrusted multilayered Nano-colloidal system of andrographolide for improved hepatoprotection. AAPS PharmSciTech. 2017;18(2):381–92.
Rai VK, Yadav NP, Sinha P, Mishra N, Luqman S, Dwivedi H, et al. Development of cellulosic polymer based gel of novel ternary mixture of miconazole nitrate for buccal delivery. Carbohydr Polym. 2014;103:126–33.
Shah PP, Desai PR, Patel AR, Singh MS. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials. 2012;33(5):1607–17.
Zhu Y, Chen X, Liu Z, Peng Y-P, Qiu Y-H. Interleukin-10 protection against lipopolysaccharide-induced neuro-inflammation and neurotoxicity in ventral mesencephalic cultures. Int J Mol Sci. 2016;17(1):25.
Ren H, Han M, Zhou J, Zheng Z-F, Lu P, Wang J-J, et al. Repair of spinal cord injury by inhibition of astrocyte growth and inflammatory factor synthesis through local delivery of flavopiridol in PLGA nanoparticles. Biomaterials. 2014;35(24):6585–94.
Paterniti I, Impellizzeri D, Di Paola R, Navarra M, Cuzzocrea S, Esposito E. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury. J Neuroinflammation. 2013;10:91.
Wang YT, Lu XM, Zhu F, Huang P, Yu Y, Zeng L, et al. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats. Biomaterials. 2011;32(31):7988–98.
Li XY, Li H, Zhang Y, Gao S, Dong CP, Wu GF. Development of albumin coupled, cholesterol stabilized, lipid nanoemulsion of methotrexate, and TNF-alpha inhibitor for improved in vivo efficacy against rheumatoid arthritis. AAPS PharmSciTech. 2017. https://doi.org/10.1208/s12249-017-0762-9.
Kandadi P, Syed MA, Goparaboina S, Veerabrahma K. Albumin coupled lipid nanoemulsions of diclofenac for targeted delivery to inflammation. Nanomed. 2012;8(7):1162–71.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interests.
Electronic supplementary material
ESM 1
(DOCX 17 kb)
Rights and permissions
About this article
Cite this article
Chen, XG., Hua, F., Wang, SG. et al. Albumin-Conjugated Lipid-Based Multilayered Nanoemulsion Improves Drug Specificity and Anti-Inflammatory Potential at the Spinal Cord Injury gSite after Intravenous Administration. AAPS PharmSciTech 19, 590–598 (2018). https://doi.org/10.1208/s12249-017-0867-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-017-0867-1